A Study to Explore if it is Possible to Successfully Obtain Optical Coherence Tomography (OCT) Imaging and Data While Patients Undergo Brain Surgery


About this study

The goal of this study is to investigate the feasibility of successfully obtaining intra-operative OCT imaging and data during standard brain surgery.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Patients must be at least 18 years old.
  • Patients must have planned surgery for one of the following:
    • Resection of a brain tumor lesion (e.g., glioma, meningioma, metastasis); or
    • Resection of non-tumoral brain tissues, such as surgery as part of seizure treatment, vascular pathology, hydrocephalus or brain lesion surgeries when non-tumoral tissues are often resected in order for the surgeon to assess the tumoral site.
  • Patients must have a Karnofsky performance status ≥ 60%.
  • Patients must have normal bone marrow function with hematocrit ≥ 26%, platelet ≥ 100.000 prior to entering this study.
  • Patient or LAR willing to provide written informed consent.

Exclusion Criteria:

  • Patients with a history of any brain infections

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Jacksonville, Fla.

Mayo Clinic principal investigator

Alfredo Quinones-Hinojosa, M.D.

Open for enrollment

Contact information:

Tito Vivas-Buitrago M.D.



More information


Publications are currently not available

Study Results Summary

Not yet available

Supplemental Study Information

Not yet available

Additional contact information

Cancer-related trials contact form

Phone: 855-776-0015 (toll-free)

International patient clinical studies questions